ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis

Journal of Clinical Investigation

Volumn 103, Issue 10, 1999, Pages 1379-1389

  Kälin, Nanette ^a   Claaß, Andreas ^b   Sommer, Martin ^b   Puchelle, Edith ^c   Tümmler, Burkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ARTICLE; CYSTIC FIBROSIS; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC LINKAGE; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; AMINO ACID SEQUENCE; CASE CONTROL STUDY; GENE DELETION; GENE EXPRESSION; GENETICS; INTESTINE; METABOLISM; NOSE POLYP; RESPIRATORY SYSTEM; SWEAT GLAND;

AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; NASAL POLYPS; RESPIRATORY SYSTEM; SEQUENCE DELETION; SWEAT GLANDS; TISSUE DISTRIBUTION;

EID: 0032588980     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5731     Document Type: Article

References (74)

1. Welsh, M.J., Tsui, L.-C., Boat, T.F., and Beaudet, A.L. 1995. Cystic fibrosis. In The metabolic and molecular bases of inherited disease. 7th edition. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 3799-3876.
2. Cheng, S.H., et al. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:827-834.
3. Gregory, R.J., et al. 1991. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11:3886-3893.
4. Zhang, F., Kartner, N., and Lukacs, G.L. 1998. Limited proteolysis as a probe for arrested conformational maturation of ΔF508 CFTR. Nat. Struct. Biol. 5:180-183.
5. Pind, S., Riordan, J.R., and Williams, D.B. 1994. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulatory. J. Biol. Chem. 269:12784-12788.
6. Yang, Y., Janich, S., Cohn, J.A., and Wilson, J.M. 1993. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl. Acad. Sci. USA. 90:9480-9483.
7. Sato, S., Ward, C.L., and Kopito, R.R. 1998. Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro. J. Biol. Chem. 273:7189-7192.
8. Ward, C.L., Omura, S., and Kopito, R.R. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 83:121-127.
9. Jensen, T.J., et al. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 83:129-135.
10. Denning, G.M., et al. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 358:761-764.
11. Sato, S., Ward, C.L., Krouse, M.E., Wine, J.J., and Kopito, R.R. 1996. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271:635-638.
12. Brown, C.R., Hong-Brown, L.Q., Biwersi, J., Verkman, A., and Welsh, W. 1996. Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones. 1:117-125.
13. Lukacs, G.L., et al. 1993. The ΔF508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. J. Biol. Chem. 268:21592-21598.
14. Lukacs, G.L., et al. 1994. Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13:6076-6086.
15. Haws, C.M., et al. 1996. ΔF508 CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am. J. Physiol. 270:C1544-C1555.
16. Dalemans, W., et al. 1991. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature. 354:526-528.
17. Drumm, M.L., et al. 1991. Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes. Science. 254:1797-1799.
18. Engelhardt, J.F., et al. 1992. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2:240-247.
19. Kartner, N., Augustinas, O., Jensen, T.J., Naismith, A.L., and Riordan, J.R. 1992. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland. Nat. Genet. 1:321-327.
20. Rommens, J., et al. 1990. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am. J. Hum. Genet. 46:395-396.
21. Marino, C.R., Matovcik, L.M., Gorelick, F.S., and Cohn, J.A. 1991. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J. Clin. Infest. 88:712-716.
22. Annereau, J.-P., et al. 1997. A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 407:303-308.
23. Dupuit, F., et al. 1995. CFTR and differentiation markers expression in non-CF and ΔF508 homozygous CF nasal epithelium. J. Clin. Invest. 96:1601-1611.
24. Bjerknes, M., and Cheng, H. 1981. Methods for the isolation of intact epithelium from the mouse intestine. Anat. Rec. 199:565-574.
25. Langridge-Smith, J.E., Field, M., and Dubinsky, W.P. 1983. Isolation of transporting plasma membrane vesicles from bovine tracheal epithelium. Biochim. Biophys. Acta. 731:318-328.
26. Denning, G.M., Ostedgaard, L.S., Cheng, S.H., Smith, A.E., and Welsh, M.J. 1992. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J. Clin. Invest. 89:339-349.
27. Brézillon, S., et al. 1995. Decreased expression of CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab. Invest. 72:191-200.
28. Cohn J.A., et al. 1993. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 105:1857-1864.
29. Cohn, J.A., Melhus, O., Page, L.J., Dittrich, K.L., and Vigna, S.R. 1991. CFTR: development of high-affinity antibodies and localization in sweat gland. Biochem. Biophys. Res. Commun. 181:36-43.
30. Kartner, N., and Riordan, J.R. 1998. Characterization of polyclonal and monoclonal antibodies to cystic fibrosis transmembrane conductance regulator. Methods Enzymol. 292:629-652.
31. Ameen, N.A., Ardito, T., Kashgarian, M., and Marino, C.R. 1995. A unique subset of rat and human intestinal villus cells express the cystic fibrosis transmembrane conductance regulator. Gastroenterology. 108:1016-1023.
32. Strong, T.V., Boehm, K., and Collins, F.S. 1994. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridisation. J. Clin. Invest. 93:347-354.
33. Puchelle, E., et al. 1992. Differential localization of cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am. J. Rispir. Cell Mol. Biol. 7:485-491.
34. Berschneider, H.M., et al. 1988. Altered intestinal chloride transport in cystic fibrosis. FASEB J. 2:2625-2629.
35. Hayden, U.L., and Carey, H.V. 1996. Cellular localization of cystic fibrosis transmembrane conductance regulator protein in piglet and mouse intestine. Cell Tissue Res. 283:209-213.
36. Hoogeveen, A.T., et al. 1991. Immunological localization of cystic fibrosis candidate gene products. Exp. Cell Res. 193:435-437.
37. - channel is functional when retained in endoplasmic reticulum of mammalian cells. J. Biol. Chem. 270:12347-12350.
38. Bradbury, N.A., Cohn, J.A., Venglarik, C.J., and Bridges, R.J. 1994. Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles. J. Biol. Chem. 269:8296-8302.
39. Zhang, Y., Doranz, B., Yankaskas, J.R., and Engelhardt, J.F. 1995. Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. J. Clin. Invest. 96:2997-3004.
40. Jilling, T., and Kirk, K.L. 1996. Cyclic AMP and chloride-dependent regulation of apical constitutive secretory pathway in colonic epithelial cells. J. Biol. Chem. 271:4381-4387.
41. Engelhardt, J.F., et al. 1994. Coupled secretion of chloride and mucus in skin of Xenopus laevis: possible role for CFTR. Am. J. Physiol. 267:C491-C500.
42. Montserrat, C., Merten, M., and Figarella, C. 1996. Defective ATP-dependent mucin secretion by cystic fibrosis pancreatic epithelial cells. FEBS Lett. 393:264-268.
43. Prince, L.S., Workman, R.B., Jr., and Marchase, R.B. 1994. Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chlo-ride channel. Proc. Natl. Acad. Sci. USA 91:5192-5196.
44. Pollard, H.B., et al. 1984. An osmotic mechanism for exocytosis from dissociated chromaffin cell. J. Biol. Chem. 259:1114-1121.
45. Mills, C.L., Pereira, M.M.C., Dormer, R.L., and McPherson, M.A. 1992. An antibody against CFTR-derived peptide incorporated into living sub-mandibular cells, inhibits beta-adrenergic stimulation of mucin secretion. Biochem. Biophys. Res. Commun. 188:1146-1152.
46. Kuver, R.,et al. 1994. Constitutive mucin secretion linked to CFTR expression. Biochem Biophys. Res. Commun. 203:1457-1462.
47. Inglis, S.K., Corboz, M.R., Taylor, A.E., and Ballard, S.T. 1997. Effect of anion transport inhibition on mucus secretion by airway submucosal glands. Am. J. Physiol. 272:L372-L377.
48. Merlin, D., et al. 1994. ATP-stimulated electrolyte and mucin secretion in the human goblet cell line HT29-Cl.16E. J. Membr. Biol. 137:137-149.
49. - transport and cystic fibrosis transmembrane conductance regulator mRNA in human intesrinal cells. J. Biol. Chem. 266:4495-4499.
50. Rich, D.P., et al. 1990. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature. 347:358-363.
51. Bebok, Z., et al. 1998. Activation of ΔF508 CFTR in an epithelial monolayer Am. J. Physiol. 275:C599-C607.
52. Hollande, E., et al. 1998. Targeting of CFTR protein is linked to the polarization of human pancreatic duct cells in culture. Eur. J. Cell Biol. 76:220-227.
53. Zeiher, B.G., et al. 1995. A mouse model for the ΔF508 allele of cystic fibrosis. J. Clin. Invest. 96:2051-2064.
54. Colledge, W.H., et al. 1995. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nat. Genet. 10:445-452.
55. French, P.J., et al. 1996. A ΔF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J. Clin. Invest. 98:1304-1312.
56. Riordan, J.R., et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1073.
57. White, N.L., Higgins, C.F., and Trezise, A.E.O. 1998. Tissue-specific in vivo transcription start sites of the human and murine cystic fibrosis genes. Hum. Mol. Genet. 7:363-369.
58. Mak, V., Jarvi, K.A., Zielenski, J., Dune, P., and Tsui, L.-C. 1997. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum. Mol. Genet. 6:2099-2107.
59. Moyer, B.D., et al. 1998. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J. Biol. Chem. 273:21759-21768.
60. Cooper, S.T, and Millar, N.S. 1997. Host cell-specific folding and assembly of neuronal acetylcholine receptor α7 subunit. J. Neurochem. 68:2140-2151.
61. Saftig, P., et al. 1997. Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J. Biol. Chem. 272:18628-18635.
62. Mickle, J.E., et al. 1998. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum. Mol. Genet. 7:715-727.
63. Rubenstein, R.C., and Zeitlin, P.L. 1998. A pilot clinical trial of oral sodium 4-phenylbutyrate (buphenyl) in ΔF508-homozygous cystic fibrosis patients. Am. J. Respir. Crit. Care Med. 157:484-490.
64. Veeze, H.J., et al. 1994. Determinants of mild clinical symptoms in cystic fibrosis patients. J. Clin. Invest. 93:461-466.
65. Kelley, T.J., Thomas, K., Milgram, L.J.H., and Drumm, M.L. 1997. In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant ΔF508 in murine nasal epithelium. Proc. Natl. Acad. Sci. USA. 94:2604-2608.
66. Webster, P., Vanacore, L., Nairn, A.C., and Marino, C.R. 1994. Subcellular localization of CFTR to endosomes in a ductal epithelium. Am. J. Physiol. 267:C340-C348.
67. Takahashi, A., Watkins, S.C., Howard, M., and Frizzell, R.A. 1996. CFTR dependent membrane insertion is linked to stimulation of the CFTR chloride conductance. Am. J. Physiol. 271:C1887-C1894.
68. Bradbury, N.A., et al. 1992. Regulation of plasma membrane recycling by CFTR. Science. 256:530-532.
69. Lehrich, R.W., Alter, S.G., Webster, P., Marino, C.R., and Forrest, J.N., Jr. 1998. Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium. J. Clin. Invest. 101:737-745.
70. Schwiebert, E.M., et al. 1994. Heterotrimeric G-proteins, vesicle trafficking and CFTR chloride channels. Am. J. Physiol. 267:C272-C281.
71. Chu, C.-S., Trapnell, B.C., Curristin, S., Cutting, G.R., and Crystal, R.G. 1993. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator. Nat. Genet. 3:151-156.
72. Johnson, L.G., et al. 1992. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2:21-25.
73. Dorin, J.R., et al. 1996. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 3:797-801.
74. Zhang, Y., Jiang, Q., Dudus, L., Yankaskas, J.R., and Engelhardt, J.F. 1998. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Hum. Gene Ther. 9:635-648.